سعر فوتافيلدكس 50/1000مجم 30 قرص 2024

Vildagliptin 50 mg + metformin hydrochloride 1000 mg film-coated tablets, 30 per pack, by Future Pharmaceutical Industries (Egypt); oral antidiabetic combination.

• Adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes inadequately controlled on metformin alone, already treated with vildagliptin and metformin as separate tablets, or in combination with other antidiabetic medicines including insulin (EU SmPC).Population: Adults with type 2 diabetesEuropean Medicines Agency (EMA)

• Acute metabolic acidosis (lactic acidosis, diabetic ketoacidosis), diabetic pre-coma, severe renal failure (GFR <30 mL/min), acute conditions that may alter renal function (dehydration, severe infection, shock, intravascular iodinated contrast), among others listed.International label, same formulation · European Medicines Agency (EMA)

• Lactic acidosis (very rare, serious), especially with worsening renal function, cardiorespiratory illness or sepsis; stop temporarily in dehydration. Not a substitute for insulin and not for type 1 diabetes. Rare hepatic dysfunction with vildagliptin: liver tests before starting and during treatment.International label, same formulation · European Medicines Agency (EMA)

• No adequate data in pregnant women; the combination should not be used during pregnancy.International label, same formulation · European Medicines Agency (EMA)
• Metformin passes into human milk in low amounts; because of possible neonatal hypoglycaemia and lack of vildagliptin data, it should not be used during breastfeeding.International label, same formulation · European Medicines Agency (EMA)

English text not available for this section.